These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31685778)
1. Anti-proliferative Activities of Some Bivalent Symmetrical 5-Substituted Hydantoin Derivatives towards Human Brain Glioma U251 Cells (U251) and Human Carcinoma Cells (KB3-1). Furutachi M; Ota K; Fujisaki F; Ikeda R; Yoshikawa N; Yokota T; Takeda Y; Yokomizo K; Zhou JR; Kashige N; Miake F; Sumoto K Biol Pharm Bull; 2019; 42(11):1953-1956. PubMed ID: 31685778 [TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative Activities towards Human Brain Glioma U251 Cells and Human Carcinoma Cells (KB3-1) of Some Twin-Drug Type Bivalent C Furutachi M; Gondo T; Ikeda R; Yoshikawa N; Yokota T; Takeda Y; Yokomizo K; Zhou JR; Kashige N; Miake F; Sumoto K Biol Pharm Bull; 2019; 42(5):833-836. PubMed ID: 31061327 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of new 5-substituted hydantoins and symmetrical twin-drug type hydantoin derivatives. Fujisaki F; Aki H; Naito A; Fukami E; Kashige N; Miake F; Sumoto K Chem Pharm Bull (Tokyo); 2014; 62(5):429-38. PubMed ID: 24789925 [TBL] [Abstract][Full Text] [Related]
4. Hydantoin derivatives of L- and D-amino acids: synthesis and evaluation of their antiviral and antitumoral activity. Rajic Z; Zorc B; Raic-Malic S; Ester K; Kralj M; Pavelic K; Balzarini J; De Clercq E; Mintas M Molecules; 2006 Nov; 11(11):837-48. PubMed ID: 18007390 [TBL] [Abstract][Full Text] [Related]
5. Anti-Tumor Mechanisms of Novel 3-(4-Substituted Benzyl)-5-Isopropil-5- Phenylhydantoin Derivatives in Human Colon Cancer Cell Line. Obradović A; Matić M; Ognjanović B; Vuković N; Vukić M; Đurđević P; Ušćumlić G; Božić B; Nedeljković BB Anticancer Agents Med Chem; 2019; 19(12):1491-1502. PubMed ID: 31840594 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells. Basappa ; Ananda Kumar CS; Nanjunda Swamy S; Sugahara K; Rangappa KS Bioorg Med Chem; 2009 Jul; 17(14):4928-34. PubMed ID: 19556138 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents. Zhang M; Liang YR; Li H; Liu MM; Wang Y Bioorg Med Chem; 2017 Dec; 25(24):6623-6634. PubMed ID: 29126741 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: a SAR study. Ananda Kumar CS; Kavitha CV; Vinaya K; Benaka Prasad SB; Thimmegowda NR; Chandrappa S; Raghavan SC; Rangappa KS Invest New Drugs; 2009 Aug; 27(4):327-37. PubMed ID: 18839066 [TBL] [Abstract][Full Text] [Related]
9. 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line. Zuliani V; Carmi C; Rivara M; Fantini M; Lodola A; Vacondio F; Bordi F; Plazzi PV; Cavazzoni A; Galetti M; Alfieri RR; Petronini PG; Mor M Eur J Med Chem; 2009 Sep; 44(9):3471-9. PubMed ID: 19268405 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of some 5-dialkylaminomethylhydantoins and related derivatives. Fujisaki F; Toyofuku K; Egami M; Ishida S; Nakamoto N; Kashige N; Miake F; Sumoto K Chem Pharm Bull (Tokyo); 2013; 61(10):1090-3. PubMed ID: 24088702 [TBL] [Abstract][Full Text] [Related]
11. Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products. Mudit M; Khanfar M; Muralidharan A; Thomas S; Shah GV; van Soest RW; El Sayed KA Bioorg Med Chem; 2009 Feb; 17(4):1731-8. PubMed ID: 19195897 [TBL] [Abstract][Full Text] [Related]
12. Platinum(IV) complexes with some derivatives of 5-methyl-5-(4-pyridyl) hydantoin. Synthesis, study and comparative pharmacological investigation. Bakalova A; Buyukliev R; Ivanova Z; Momekov G; Ivanov D Drug Res (Stuttg); 2013 Aug; 63(8):420-3. PubMed ID: 23677699 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, Anticancer Evaluation and Docking Study of 3- Benzyloxyhydantoin Derivatives. Liu J; Zhang K; Mai X; Wei J; Liao Y; Zhong Y; Liu Y; Feng L; Liu C Med Chem; 2016; 12(1):37-47. PubMed ID: 26152144 [TBL] [Abstract][Full Text] [Related]
14. Study on the Synthesis, Characterization and Bioactivities of 3-Methyl-9'-fluorenespiro-5-hydantoin. Marinova P; Marinov M; Kazakova M; Feodorova Y; Slavchev A; Blazheva D; Georgiev D; Penchev P; Sarafian V; Stoyanov N Acta Chim Slov; 2016; 63(1):26-32. PubMed ID: 26970785 [TBL] [Abstract][Full Text] [Related]
15. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents. Azizmohammadi M; Khoobi M; Ramazani A; Emami S; Zarrin A; Firuzi O; Miri R; Shafiee A Eur J Med Chem; 2013 Jan; 59():15-22. PubMed ID: 23202485 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]